Acta Med. 2000, 43: 3-8

https://doi.org/10.14712/18059694.2019.109

Paroxysmal Nocturnal Hemoglobinuria (Membrane Defect, Pathogenesis, Aplastic Anemia, Diagnosis)

Ladislav Chrobák

University Teaching Hospital in Hradec Králové, Department of Clinical Hematology, Hradec Králové, Czech Republic

Received February 1, 2000
Accepted March 1, 2000

References

1. Araten DJ, Nafa K, Pakde Suwan K et al. Clonal populations of hematopoietic cells with paroxysmal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci U.S.A. 1999; 96:5209-14. <https://doi.org/10.1073/pnas.96.9.5209> <PubMed>
2. Armstrong C, Schubert J, Veda et al. Affected paroxysmal nocturnal haemoglobinuria T lymphocytes harbour a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A thy-1-murine lymphoma mutants. J Biol Chem 1991; 267:25347-51.
3. Bemba M, Guardiola P, Garderet L. Bone marrow transplantation for paroxysmal nocturnal haemoglobinuria. Br J Haematol 1999; 105:366-8. <https://doi.org/10.1111/j.1365-2141.1999.01374.x>
4. Bessler M, Fehr J. fc(III receptors) (FcR III) on granulocytes: a new specific and sensitivity test for paroxysmal nocturnal haemoglobinuria. Eur J Haematol 1991; 47:179-82. <https://doi.org/10.1111/j.1600-0609.1991.tb01552.x>
5. Bessler M, Mason GJ, Hillmen P et al. Somatic mutations and cellular selection in paroxysmal nocturnal hemoglobinuria. Lancet 1994; 343:951-3. <https://doi.org/10.1016/S0140-6736(94)90068-X>
6. Birgens HS, Hancke S, Rosenklint A et al. Ultrasonic demonstration of clinical and subclinical hepatic venous thrombosis in paroxysmal nocturnal haemoglobinuria. Br J Haematol 1986; 64:737-43. <https://doi.org/10.1111/j.1365-2141.1986.tb02235.x>
7. Brodsky RA, Vala MS, Barber JP et al. Resistance to apoptosis caused by PIGA gene mutation in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U.S.A. 1997; 94:8756-60. <https://doi.org/10.1073/pnas.94.16.8756> <PubMed>
8. Crosby WH. Paroxysmal nocturnal hemoglobinuria: relation of the clinical manifestations to underlying pathogenic mechanisms. Blood 1953; 8:769-812.
9. Dacie JV, Gilpin A. Refractory anaemia (Fanconi type). Arch Dis Child 1944; 19:155-62. <https://doi.org/10.1136/adc.19.100.155> <PubMed>
10. Dacie JV, Israels MCG, Wilkinson JF. Paroxysmal nocturnal hemoglobinuria of the Marchiafave type. Lancet 1938; 1:479-91. <https://doi.org/10.1016/S0140-6736(00)89566-5>
11. Dacie JV, Lewis SM. Paroxysmal nocturnal hemoglobinuria: variation in clinical severity and association with bone-marrow hypoplasia. Br J. Haematol 1961; 7:442-57. <https://doi.org/10.1111/j.1365-2141.1961.tb00354.x>
12. Dacie JV, Mollison PL. Survival of transfused erythrocytes from a donor with nocturnal haemoglobinuria. Lancet 1949; 1:390-2. <https://doi.org/10.1016/S0140-6736(49)90704-7>
13. De Sandre G, Gihotto G, Mastella G. L’aceticolinesterase eritrocitaria. II. Rapporti con le malatie emolitiche. Acta Med Patav 1956; 16:310-35.
14. Dunkas MA, Di Lorenzo PE, Mohler DN. Intestinal infarction caused by paroxysmal nocturnal hemoglobinuria. Am J Hematol 1987; 16:75-7.
15. Dunn DE, Nagakura S, Tanawattana-Charoen P et al. The PNH phenotype (GPIanchored protein-deficiency) protects hematopoietic target against lymphotoxic attack (Abstract). Blood 1997; 90(suppl 1):407a.
16. Dunn DE, Tanawattana-Charoen P, Boccuni P et al. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med 1999; 131:401-408. <https://doi.org/10.7326/0003-4819-131-6-199909210-00002>
17. Enneking J. Eine neue Form intermitierender Hämoglobinurie (hemoglobinuria paroxysmalis nocturna). Klin Wschr 1928; 7:2045-7. <https://doi.org/10.1007/BF01846778>
18. Hall SE, Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 1996; 87:5332-40.
19. Ham TH. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria. Study of the mechanism of hemolysis in relation to acid-base equilibrium. New Engl J Med 1937; 217:915-7. <https://doi.org/10.1056/NEJM193712022172307>
20. Ham TH, Dingle JH. Studies on destruction of red cells. II. chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria: certain immunological aspects of the hemolytic mechanism with special reference to serum complement. J Clin Invest 1939; 18:657-73. <https://doi.org/10.1172/JCI101081> <PubMed>
21. Hartman RC, Jenkins DE, Arnold AB. Diagnostic specificity of the sucrose hemolysis test for paroxysmal nocturnal hemoglobinuria. Blood 1970; 35:462-75.
22. Harris JW, Koscick R, Lazarus HM et al. Leukemia arising out of paroxysmal nocturnal hemoglobinuria. Leukemia Lymph. 1999; 32:401-26. <https://doi.org/10.3109/10428199909058399>
23. Hillmen P, Bessler M, Mason PJ et al. Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U.S.A. 1993; 90:5272-76. <https://doi.org/10.1073/pnas.90.11.5272> <PubMed>
24. Hillmen P, Lewis PM, Bessler M et al. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995; 333:1253-58. <https://doi.org/10.1056/NEJM199511093331904>
25. Holguin MH, Frederick LR, Bernshaw NY et al. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 1989; 84:7-17. <https://doi.org/10.1172/JCI114172> <PubMed>
26. Horikawa K, Nakakuma H, Kawaguchi T. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome. Blood 1997; 90:2716-22.
27. Chrobák L, Brabec V. Paroxysmální noční hemoglobinurie. Thomayerova sbírka, SZN Praha 1965. 102 pp.
28. Chrobák L, Brabec V, Wiedermann B. et al. Paroxysmale nächliche Hämoglobinurie. Bericht über 8 Fälle unter besonderer Berücksichtigung von Panzytopenie und Knochenmarkaplasie. Folia haemat (Lpz) 1964; 82:256-293.
29. Chrobák L, Groh J. Paroxysmální noční hemoglobinurie. Sborník věd. prací VLA J. Ev. P. 1957; 5:135-155.
30. Chrobák L, Toušková M, Žák P et al. Paroxysmální noční hemoglobinurie (patogeneze a vztah k dřeňové aplazii). Hematol. Transfusiol. 2000; v tisku.
31. Kawahara K, Witherspoon RP, Storb R. Marrow transplantation for paroxysmal nocturnal hemoglobinuria. Am J. Hematol 1992; 39:283-8. <https://doi.org/10.1002/ajh.2830390409>
32. Kolanus HJ, Schmidt RE. The PIG-anchoring defect in NK lymphocytes of PNH patients. Blood 1990; 76:1181-7.
33. Leibowitz AI, Hertmann RC. Annotation: The Budd-Chiari syndrome and paroxysmal nocturnal haemoglobinuria. Br J Haematol 1981; 48:1-6. <https://doi.org/10.1111/j.1365-2141.1981.00001.x>
34. Letman H. Possible paroxysmal nocturnal hemoglobinuria with pronounced pancytopenia, reticulocytopenia, and without hemoglobinuria simulating aplastic anemia. Blood 1952; 7:842-49.
35. Lewis SM, Dacie JV. Neutrophil (leukocyte) alkaline phosphatase in paroxysmal nocturnal hemoglobinuria. Br J Haematol 1965; 11:549-56. <https://doi.org/10.1111/j.1365-2141.1965.tb00099.x>
36. Lewis SM, Szur L, Dacie JV. The pattern of erythrocyte destruction in haemolytic anaemia as studied with radioactive chromium. Br J Haematol 1960; 6:122-39. <https://doi.org/10.1111/j.1365-2141.1960.tb06224.x>
37. Luzzatto L. Paroxysmal nocturnal haemoglobinuria. Haematology 1996; Panache Design Singapore, p. 120-7.
38. Luzzatto L, Bessler M. The dual pathogenesis of paroxysmal nocturnal hemoglobinuria. Current Opinion Hematol 1996; 3:101-3. <https://doi.org/10.1097/00062752-199603020-00001>
39. Luzzatto L, Bessler M, Rotoli B. Somatic mutation in paroxysmal nocturnal hemoglobinuria: A blessing in disguise? Cell 1997; 80:1-4. <https://doi.org/10.1016/S0092-8674(00)81850-4>
40. Marchiafava E. Anemia emolitica con emosiderinuria perpetua. Policlinico, Sez Med 1928; 35:105-17.
41. Marks J. The Marchiafava-Micheli syndrome (Paroxysmal nocturnal haemoglobinuria). Quart J Med 1949; 18:105-21.
42. Mc Mullin MF, Hillmen P, Jackson J et al. Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal haemoglobinuria. J Intern Med 1994; 235:85-9. <https://doi.org/10.1111/j.1365-2796.1994.tb01037.x>
43. Meri S, Morgan BP, Davies A et al. Human protectin (CD 59), an 18.000-20.000 MW complement lysis restricting factor, inhibits C 5b-8 catalysed insertion of C9 into lipid bilayers. Immunulogy 1990; 7:1-9.
44. Miyata T, Takeda J, Iida Y et al. The cloning of PIG-A, a component in the early step of GPI-achor biosynthesis. Science 1993; 259:1318-20. <https://doi.org/10.1126/science.7680492>
45. Murakami Y, Kinoshita T, Maeda Y. et al. Different roles of glycosylphosphatidylinositol in various hematopoietic cells as revealed by a mouse model of paroxysmal nocturnal hemoglobinuria. Blood 1999; 94:2963-70.
46. Nakahata JI, Takahashi M, Fuse I et al. Paroxysmal nocturnal hemoglobinuria with myelofibrosis: progression to acute myeloblastic leukemia. Leukemia Lymph 1993; 92:137-42. <https://doi.org/10.3109/10428199309059582>
47. Nafa K, Bessler M, Castro-Malaspina H et al. The spectrum of somatic mutation in the PIG-A gene in paroxysmal nocturnal hemoglobinuria includes large deletions and small duplications. Blood Cells Mol Dis 1998; 24:370-84. <https://doi.org/10.1006/bcmd.1998.0203>
48. Nafa K, Mason PJ, Hillman P et al. Mutations in the PIG-A gene causing Paroxysmal Nocturnal Hemoglobinuria are mainly of the frameshift type. Blood 1995; 86:4650-5.
49. Nakakuma H, Nagakura S, Horikawa K et al. Interleukin-2-dependent T-cell lines established from paroxysmal nocturnal hemoglobinuria patients. Blood 1994; 84:309-14.
50. Nakakuma H, Nagakura S, Iwamoto N et al. Paroxysmal nocturnal hemoglobinuria clone in bone marrow of patients with pancytopenia. Blood 1995; 85:1371-6.
51. Nicholson-Weller A, March JP, Rosenfeld SJ et al. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Proc Natl Acad Sci U.S.A. 1983; 80:5430-3. <https://doi.org/10.1073/pnas.80.16.5066> <PubMed>
52. One SB, Osunkoya BO, Luzzatto L. Paroxysmal nocturnal hemoglobinuria: evidence for monoclonal origin of abnormal red cells. Blood 1970; 36:145-52.
53. Plongh M, Plesner T, Roune E et al. The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria. Blood 1992; 79:1447-55.
54. Rawstron AC, Rollinson SJ, Richards S. The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment. Br J Haematol 1999; 107:148-53. <https://doi.org/10.1046/j.1365-2141.1999.01676.x>
55. Rosse WF. Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria. Blood 1990; 75:1595-1601.
56. Rosse WJ, Dacie JV. Immune lysis of normal human and paroxysmal nocturnal haemoglobinuria (PNH) red blood cells: I. The sensitivity of PNH red cells to lysis by complement and specific antibody. J Clin Invest 1966; 45:736-48. <https://doi.org/10.1172/JCI105388> <PubMed>
57. Rosse WF, Ware RE. The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood 1995; 86:3277-86.
58. Rotoli B, Bessler M, Afinito F, del Vecchio L. Membrane proteins in paroxysmal nocturnal haemoglobinuria. Blood Reviews 1993; 7:75. <https://doi.org/10.1016/S0268-960X(05)80017-7>
59. Rotoli B, Luzzatto L. Paroxysmal nocturnal hemoglobinuria. Semin. Hematol 1989; 26:201.
60. Rotoli B, Robledo R, Scarpato N et al. Two populations of erythroid cell progenitors in paroxysmal nocturnal haemoglobinuria. Blood 1984; 64:847-51.
61. Sašo R, Marsh J, Čevreska L et al. Bone marrow transplants for paroxysmal nocturnal hemoglobinuria. Br J Haematol 1999; 104:392-6. <https://doi.org/10.1046/j.1365-2141.1999.01195.x>
62. Shichishima T, Terasawa T, Hashimoto C et al. Discordant and hetorogenous expression of GPI-anchored membrane proteins on leukemic cells in a patient with paroxysmal nocturnal hemoglobinuria. Blood 1993; 81:1855-62.
63. Shichishima T, Terasawa T, Saitoh Y et al. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour cytometry with monoclonal antibodies to DAF and CD 59/MACIF. Br J Haematol 1993; 85:378-86. <https://doi.org/10.1111/j.1365-2141.1993.tb03182.x>
64. Schubert J, Uchiechowski P, Delany P et al. The PIG-anchoring defect in NK lymphocytes of PNH patients. Blood 1990; 76:1181-7.
65. Stafford AA, Nagarajan S, Weinberg JB et al. PIG-A, DAF and protooncogene expression in paroxysmal nocturnal haemoglobinuria - associated acute myelogenous leukaemia blasts. Br J Haematol 1995; 89:72-8. <https://doi.org/10.1111/j.1365-2141.1995.tb08908.x>
66. Strübing P. Paroxysmale Hämoglobinurie. Dtsch Med Wschr 1882; 8:1-3. <https://doi.org/10.1055/s-0029-1196307>
67. Takeda J, Miyata T, Kawagoe K et al. Deficiency of the PIG-A gene in paroxysmal nocturnal haemoglobinuria. Cell 1993; 73:703-11. <https://doi.org/10.1016/0092-8674(93)90250-T>
68. Tremml G, Dominguez C, Rosti V et al. Increased sensitivity to complement and decreased red blood cell life span in mice mosaic for a non-functional Piga gene. Blood 1999; 94:2945-54.
69. Tichelli A, Gratwohl A, Nissen C et al. Late haematological complications in severe aplastic anaemia. Br J Haematol 1988; 69:413-18. <https://doi.org/10.1111/j.1365-2141.1988.tb02382.x>
70. Toušek M. Paroxysmale Nachthämoglobinurie. Folia haemat (Lpz) 1955; 73:284-300.
71. Van den Bergh HAA. Ictère hémolytigue avec crises hémoglobinurigues. Fragilité globulaire. Rev Méd 1911; 31:63-9.
72. Van der Schoot CE, Huizinga TW, Van’t Veer-Korthof ET et al. Deficiency of glycosyl-phosphatidyl-inositol-linked membrane proteins of leukocytes in paroxysmal nocturnal hemoglobinuria. Description of a new diagnostic cytofluorometric assay. Blood 1990; 76:1853-9.
73. Voswinckel P. Der schwarze Urine Berlin, Germany Blackwell, 1993. Panache Design Singapore, p. 120-7.
74. Wiedmer T, Hall SE, Ortel TL et al. Complement induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 1993; 82:1192-6.
75. Yamashina M, Ueda E, Kinoshita T et al. Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD 59) as a cause of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1990; 323:1184-1189. <https://doi.org/10.1056/NEJM199010253231707>
76. Young NS, Barret AJ. The treatment of acquired aplastic anemia. Blood 1995; 85:3367-77.
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive